RSSDI Repository, Complications of Diabetes Demonstration
RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

Advanced Search
  • Home/
  • Article /
  • Immunogenicity of 2 and 3 doses of the quadrivalent human papillomavirus vaccine up to 120 months postvaccination: follow-up of a randomized clinical trial

Immunogenicity of 2 and 3 doses of the quadrivalent human papillomavirus vaccine up to 120 months postvaccination: follow-up of a randomized clinical trial

Add to Collection
RCTs R Donken, SRM Dobson, KD Marty… - Clinical Infectious …, 2020 - academic.oup.com

Chapter : Section15
Journal Year : 2020
Cited by : 18

… Here, we report the antibody responses up to 120 months after vaccination with 2D or 3D of the quadrivalent HPV (4vHPV) vaccine. … Early findings from an Indian study …..... Read More

Keywords : ['quadrivalent human papillomavirus vaccine', 'randomized clinical trial', 'month postvaccination followup', 'immunogenicity', 'dose']
PubMed Link : https://academic.oup.com/cid/article-abstract/71/4/1022/5564371
Google Scholar Link : https://scholar.google.com/scholar?cites=9613530631488574214&as_sdt=5,45&sciodt=0,45&hl=en&num=20